Corvus Pharmaceuticals, Inc. (CRVS)
10.90
-0.03
(-0.27%)
USD |
NASDAQ |
Oct 02, 16:00
10.91
+0.01
(+0.09%)
After-Hours: 20:00
Corvus Pharmaceuticals Market Cap : 916.92M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 916.92M |
| October 01, 2026 | 919.44M |
| September 30, 2026 | 969.07M |
| September 29, 2026 | 989.26M |
| September 28, 2026 | 998.52M |
| September 25, 2026 | 977.48M |
| September 24, 2026 | 992.63M |
| September 23, 2026 | 1.055B |
| September 22, 2026 | 1.131B |
| September 21, 2026 | 1.045B |
| September 18, 2026 | 1.057B |
| September 17, 2026 | 1.056B |
| September 16, 2026 | 1.029B |
| September 15, 2026 | 1.089B |
| September 14, 2026 | 1.103B |
| September 11, 2026 | 1.086B |
| September 10, 2026 | 1.089B |
| September 09, 2026 | 1.121B |
| September 08, 2026 | 1.172B |
| September 04, 2026 | 1.210B |
| September 03, 2026 | 1.232B |
| September 02, 2026 | 1.195B |
| September 01, 2026 | 1.200B |
| August 31, 2026 | 1.181B |
| August 28, 2026 | 1.191B |
| Date | Value |
|---|---|
| August 27, 2026 | 1.238B |
| August 26, 2026 | 1.239B |
| August 25, 2026 | 1.225B |
| August 24, 2026 | 1.185B |
| August 21, 2026 | 1.216B |
| August 20, 2026 | 1.205B |
| August 19, 2026 | 1.295B |
| August 18, 2026 | 1.248B |
| August 17, 2026 | 1.254B |
| August 14, 2026 | 1.253B |
| August 13, 2026 | 1.274B |
| August 12, 2026 | 1.266B |
| August 11, 2026 | 1.239B |
| August 10, 2026 | 1.156B |
| August 07, 2026 | 1.171B |
| August 06, 2026 | 1.166B |
| August 05, 2026 | 1.172B |
| August 04, 2026 | 1.171B |
| August 03, 2026 | 1.124B |
| July 31, 2026 | 1.115B |
| July 30, 2026 | 1.109B |
| July 29, 2026 | 1.097B |
| July 28, 2026 | 1.119B |
| July 27, 2026 | 1.086B |
| July 24, 2026 | 1.099B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.434B |
| Alnylam Pharmaceuticals, Inc. | 29.38B |
| Savara, Inc. | 987.97M |
| Vericel Corp. | 2.055B |
| Biogen, Inc. | 32.48B |
Market Cap Related Metrics
| Price to Book Value | 4.069 |
| Price | 10.90 |
| Earnings Yield | -5.67% |